Get the Stockscreener App
4.68
3.51%
-0.17
After Hours:
4.67
-0.010
-0.21%
Teladoc Health Inc stock is traded at $4.68, with a volume of 7.44M.
It is down -3.51% in the last 24 hours and down -37.27% over the past month.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
See More
Previous Close:
$4.85
Open:
$4.83
24h Volume:
7.44M
Relative Volume:
1.28
Market Cap:
$830.58M
Revenue:
$2.54B
Net Income/Loss:
$-207.36M
P/E Ratio:
-3.9328
EPS:
-1.19
Net Cash Flow:
$151.25M
1W Performance:
-4.68%
1M Performance:
-37.27%
6M Performance:
-30.97%
1Y Performance:
-64.11%
1-Day Range:
$4.53
$4.8383
1-Week Range:
$4.53
$5.075
52-Week Range:
$4.53
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, TEM, BTSG, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
4.68 | 860.75M | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
177.04 | 30.74B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.61 | 9.94B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
40.06 | 7.10B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
76.92 | 6.69B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
25.96 | 5.03B | 550.17M | 201.35M | 232.07M | 1.00 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Here's Why I Still Wouldn't Touch Teladoc With a 10‑Foot Pole - Nasdaq
Teladoc Health expands virtual care access through HealthKey partnership - Traders Union
Teladoc Health (NYSE:TDOC) Sets New 12-Month LowHere's What Happened - MarketBeat
HIMS Dips 55.8% in 3 Months: Should You Still Hold the Stock or Sell? - Finviz
Telemedicine Market to Reach US$ 488.89 Billion by 2033 at 16.8% - openPR.com
Dow Update: Is Teladoc Health Inc. stock positioned for long term growthTrade Ideas & Short-Term High Return Strategies - mfd.ru
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance Singapore
Digital Health Market to Reach US$ 1,907.21 Billion by 2033, - openPR.com
Online Doctor Consultation Market Set for Explosive Growth - openPR.com
Stock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit - The Motley Fool
Teladoc (TDOC) Sees Increased Bullish Activity in Options Market - GuruFocus
Allianz Asset Management GmbH Grows Holdings in Teladoc Health, Inc. $TDOC - MarketBeat
United States Telehealth Solutions Market to Grow at 32.1% CAGR - openPR.com
Teladoc (TDOC) Sees Surge in Bullish Option Activity - GuruFocus
Best Telemedicine and Telehealth Stocks for 2026 - The Motley Fool
Teladoc Health, Inc. $TDOC Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Given Average Rating of "Hold" by Analysts - MarketBeat
Can Teladoc Health Inc reach all time highs this year - baoquankhu1.vn
Teladoc Health drives confidence in hypertension care - Traders Union
Teladoc Health to Announce Fourth Quarter 2025 Financial Results - The Manila Times
Jim Cramer on Teladoc: "I Don't See Any Reason to Own It" - Finviz
Jim Cramer on Teladoc: “I Don’t See Any Reason to Own It” - Insider Monkey
Lacklustre Performance Is Driving Teladoc Health, Inc.'s (NYSE:TDOC) 28% Price Drop - 富途牛牛
Teladoc Health, Inc.'s (NYSE:TDOC) 28% Dip In Price Shows Sentiment Is Matching Revenues - simplywall.st
Teladoc Health, Inc. (TDOC) Investor Outlook: Is The 66% Upside Within Reach? - DirectorsTalk Interviews
The Truth About Teladoc Health Inc: Is TDOC’s Telehealth Empire Still Worth Your Money? - AD HOC NEWS
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Teladoc Health (NYSE:TDOC) Hits New 12-Month LowHere's Why - MarketBeat
Teladoc Health (TDOC) Is Down 13.9% After Medicare Tightens Telehealth CoverageWhat's Changed - Sahm
(TDOC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
A Look At Teladoc Health’s Valuation As Medicare Telehealth Policy And Options Activity Drive Uncertainty - Sahm
What are Teladoc Health Inc.’s earnings expectationsJuly 2025 Volume & Low Drawdown Investment Strategies - mfd.ru
Chuck Divita on why 2026 is Teladoc’s ‘execution year’ - Healthcare Dive
Teladoc hits all-time low as a risky pattern points to a deeper dive - TradingView
Published on: 2026-01-29 14:18:31 - baoquankhu1.vn
Teleoncology Market to Reach US$ 15.03 Billion by 2032 at 15.7% - openPR.com
A Look At Teladoc Health (TDOC) Valuation As Medicare And BetterHelp Concerns Drive Volatility - Yahoo Finance
Once Medicare Stops Covering Telehealth Services, Will Teladoc Health Stock be in Trouble? - The Globe and Mail
Medicare Telehealth Uncertainty And BetterHelp Weakness Test Teladoc Valuation - Sahm
Is Teladoc Health (TDOC) A Potential Opportunity After Prolonged Share Price Weakness - Yahoo Finance
Teladoc (TDOC) Stock Falls Amid Market Uptick: What Investors Need to Know - sharewise.com
Why Teladoc (TDOC) Shares Are Plunging Today - Finviz
Teladoc Health (NYSE:TDOC) Hits New 1-Year LowShould You Sell? - MarketBeat
Are Telehealth Stocks Set to Tumble in 2026? - The Globe and Mail
Teladoc stock hits 52-week low at 6.03 USD - Investing.com
Teladoc price target lowered to $7 from $7.50 at BofA Securities - Investing.com Canada
Teladoc (TDOC) Sees Surge in Call Option Activity - GuruFocus
Teladoc offers free non-emergency care for Texans impacted by winter storm - CW33.com
Analyst Calls: What is the target price for Teladoc Health Inc stockQuarterly Market Summary & Growth Focused Entry Point Reports - baoquankhu1.vn
Teladoc’s Data-Driven 24/7 Care Upgrade Could Be A Game Changer For Teladoc Health (TDOC) - Sahm
Assessing Teladoc Health (TDOC) Valuation As Investor Caution Grows Despite Product Updates - Sahm
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.28%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):